311 related articles for article (PubMed ID: 36035124)
1. Innovative Therapeutic Approaches in Non-Alcoholic Fatty Liver Disease: When Knowing Your Patient Is Key.
Alonso-Peña M; Del Barrio M; Peleteiro-Vigil A; Jimenez-Gonzalez C; Santos-Laso A; Arias-Loste MT; Iruzubieta P; Crespo J
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445895
[TBL] [Abstract][Full Text] [Related]
2. Genetic association study identifies genetic variants for non-alcoholic fatty liver without comorbidities in the Korean population.
Kim YJ; Cho YS
Genes Genomics; 2023 Jul; 45(7):847-854. PubMed ID: 37133724
[TBL] [Abstract][Full Text] [Related]
3. Key genes associated with non-alcoholic fatty liver disease and hepatocellular carcinoma with metabolic risk factors.
Yang F; Ni B; Lian Q; Qiu X; He Y; Zhang Q; Zou X; He F; Chen W
Front Genet; 2023; 14():1066410. PubMed ID: 36950134
[No Abstract] [Full Text] [Related]
4. Unique genetic variants of lean nonalcoholic fatty liver disease: a retrospective cohort study.
Li J; Wu N; Yang Y; Zhai X; Yuan F; Zhang F; Yu N; Li D; Wang R; Wang J; Zhang L; Shi Y; He G; Liu B
BMC Endocr Disord; 2023 Jan; 23(1):11. PubMed ID: 36627697
[TBL] [Abstract][Full Text] [Related]
5. The molecular basis of the associations between non-alcoholic fatty liver disease and colorectal cancer.
Qiu T; Hu W; Rao Z; Fang T
Front Genet; 2022; 13():1007337. PubMed ID: 36568397
[No Abstract] [Full Text] [Related]
6. Comprehensive Review of Cardiovascular Disease Risk in Nonalcoholic Fatty Liver Disease.
Josloff K; Beiriger J; Khan A; Gawel RJ; Kirby RS; Kendrick AD; Rao AK; Wang RX; Schafer MM; Pearce ME; Chauhan K; Shah YB; Marhefka GD; Halegoua-DeMarzio D
J Cardiovasc Dev Dis; 2022 Nov; 9(12):. PubMed ID: 36547416
[TBL] [Abstract][Full Text] [Related]
7. Genetic variants associated with circulating liver injury markers in Mexican Americans, a population at risk for non-alcoholic fatty liver disease.
Sabotta CM; Kwan SY; Petty LE; Below JE; Joon A; Wei P; Fisher-Hoch SP; McCormick JB; Beretta L
Front Genet; 2022; 13():995488. PubMed ID: 36386790
[No Abstract] [Full Text] [Related]
8. Mechanisms Behind NAFLD: a System Genetics Perspective.
Pourteymour S; Drevon CA; Dalen KT; Norheim FA
Curr Atheroscler Rep; 2023 Nov; 25(11):869-878. PubMed ID: 37812367
[TBL] [Abstract][Full Text] [Related]
9. Trends and predictions of metabolic risk factors for acute myocardial infarction: findings from a multiethnic nationwide cohort.
Chew NWS; Chong B; Kuo SM; Jayabaskaran J; Cai M; Zheng H; Goh R; Kong G; Chin YH; Imran SS; Liang M; Lim P; Yong TH; Liew BW; Chia PL; Ho HH; Foo D; Khoo D; Huang Z; Chua T; Tan JWC; Yeo KK; Hausenloy D; Sim HW; Kua J; Chan KH; Loh PH; Lim TW; Low AF; Chai P; Lee CH; Yeo TC; Yip J; Tan HC; Mamas MA; Nicholls SJ; Chan MY
Lancet Reg Health West Pac; 2023 Aug; 37():100803. PubMed ID: 37693863
[TBL] [Abstract][Full Text] [Related]
10. Editorial: The heart of NAFLD.
Chew NWS; Kannan S; Chong B; Chin Y; Muthiah M
Front Med (Lausanne); 2023; 10():1209625. PubMed ID: 37283629
[No Abstract] [Full Text] [Related]
11. An international multidisciplinary consensus statement on MAFLD and the risk of CVD.
Zhou XD; Targher G; Byrne CD; Somers V; Kim SU; Chahal CAA; Wong VW; Cai J; Shapiro MD; Eslam M; Steg PG; Sung KC; Misra A; Li JJ; Brotons C; Huang Y; Papatheodoridis GV; Sun A; Yilmaz Y; Chan WK; Huang H; Méndez-Sánchez N; Alqahtani SA; Cortez-Pinto H; Lip GYH; de Knegt RJ; Ocama P; Romero-Gomez M; Fudim M; Sebastiani G; Son JW; Ryan JD; Ikonomidis I; Treeprasertsuk S; Pastori D; Lupsor-Platon M; Tilg H; Ghazinyan H; Boursier J; Hamaguchi M; Nguyen MH; Fan JG; Goh GB; Al Mahtab M; Hamid S; Perera N; George J; Zheng MH
Hepatol Int; 2023 Aug; 17(4):773-791. PubMed ID: 37204656
[TBL] [Abstract][Full Text] [Related]
12. The interplay between nonalcoholic fatty liver disease and atherosclerotic cardiovascular disease.
Finney AC; Das S; Kumar D; McKinney MP; Cai B; Yurdagul A; Rom O
Front Cardiovasc Med; 2023; 10():1116861. PubMed ID: 37200978
[TBL] [Abstract][Full Text] [Related]
13. Socio-Demographic, Behavioral and Psychological Factors Associated with High BMI among Adults in a Southeast Asian Multi-Ethnic Society: A Structural Equation Model.
Chew HSJ; Loong SSE; Lim SL; Tam WSW; Chew NWS; Chin YH; Chao AM; Dimitriadis GK; Gao Y; So BYJ; Shabbir A
Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111045
[TBL] [Abstract][Full Text] [Related]
14. The genetic interactions between non-alcoholic fatty liver disease and cardiovascular diseases.
Chew NWS; Chong B; Ng CH; Kong G; Chin YH; Xiao W; Lee M; Dan YY; Muthiah MD; Foo R
Front Genet; 2022; 13():971484. PubMed ID: 36035124
[TBL] [Abstract][Full Text] [Related]
15. Non-alcoholic fatty liver disease and cardiovascular disease: assessing the evidence for causality.
Brouwers MCGJ; Simons N; Stehouwer CDA; Isaacs A
Diabetologia; 2020 Feb; 63(2):253-260. PubMed ID: 31713012
[TBL] [Abstract][Full Text] [Related]
16. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis.
Targher G; Byrne CD; Lonardo A; Zoppini G; Barbui C
J Hepatol; 2016 Sep; 65(3):589-600. PubMed ID: 27212244
[TBL] [Abstract][Full Text] [Related]
17. Nonalcoholic Fatty Liver Disease: An Emerging Modern-Day Risk Factor for Cardiovascular Disease.
Hassen G; Singh A; Belete G; Jain N; De la Hoz I; Camacho-Leon GP; Dargie NK; Carrera KG; Alemu T; Jhaveri S; Solomon N
Cureus; 2022 May; 14(5):e25495. PubMed ID: 35783879
[TBL] [Abstract][Full Text] [Related]
18. Non-alcoholic fatty liver disease-related risk of cardiovascular disease and other cardiac complications.
Byrne CD; Targher G
Diabetes Obes Metab; 2022 Feb; 24 Suppl 2():28-43. PubMed ID: 34324263
[TBL] [Abstract][Full Text] [Related]
19. Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis.
Mantovani A; Csermely A; Petracca G; Beatrice G; Corey KE; Simon TG; Byrne CD; Targher G
Lancet Gastroenterol Hepatol; 2021 Nov; 6(11):903-913. PubMed ID: 34555346
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
